Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Deerfield, Ill., May 26, 2005- King Pharmaceuticals Research and Development, Inc. ("King") along with Astellas US LLC and Astellas Pharma US, Inc. ("Astellas") announced today that they have...
Japan, May 17, 2005 - Astellas Pharmaceutical Co., Ltd.(Astellas) today announced that Astellas has decided a dissolution of Astellas Medical Care Co., Ltd., its wholly owned subsidiary engaged in...
Read more about Astellas will Dissolve its Subsidiary for Home Care business
Japan, May 16, 2005 - Astellas Pharma Inc. (Astellas) today announced its decision to withdraw from its Medical Supplies and Systems Business along with the corporate strategy to concentrate on...
Read more about Astellas will Withdraw from its Medical Supplies and Systems Business
Astellas Pharma Inc. (headquarters: Tokyo; President and CEO: Toichi Takenaka; "Astellas") and Boehringer Ingelheim Pharmaceuticals, Inc. ("BIPI"), a US subsidiary of Boehringer Ingelheim of...
Follow us
